Rifaximin
Back to searchMolecule Structure
Scientific Name
Rifaximin
Description of the Drug
Rifaximin is a rifamycin-based non-systemic antibiotic used for the treatment of gastrointestinal bacterial infections, such as traveler’s diarrhea and irritable bowel syndrome, and reduction of overt hepatic encephalopathy recurrence in adults.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01220
http://www.drugbank.ca/drugs/DB01220
Brand Name(s)
Normix, Rifacol, Targaxan, Xifaxan, Xifaxanta
Company Owner(s)
Salix Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Bacterial DNA-directed RNA polymerase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2364672 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL124066 | |
PharmGKB | PA164752443 | |
DrugBank | DB01220 | |
PubChem: Thomson Pharma | 14864870 | 14864871 |
PubChem | 6436173 | |
Mcule | MCULE-7361349450 | |
PDBe | RXM | |
BindingDB | 50347620 | |
EPA CompTox Dashboard | DTXSID7045998 | |
DrugCentral | 2379 | |
ChemicalBook | CB5244184 | |
rxnorm | RIFAXIMIN | XIFAXAN |
PubChem: Drugs of the Future | 12012727 | |
ChEBI | 75246 | |
ZINC | ZINC000169621200 |